Identification of a Molecular Subtype of High Grade Serous Ovarian Cancer Representing MAPK Pathway Activation and Platinum Resistance

Brown C. A.; McCabe N.; Gourley C.; McCavigan A.; Michle C. O.; El-Helai A.; Price B.; McGivern N.; Churchman M.; OBrien E. J.; Hill L.; Davison T. S.; Williams A.; McCluggage W. G.; Keating K. E.; Harkin D. P.; Kennedy R.

首页> 外文期刊>The Journal of molecular diagnostics: JMD >Identification of a Molecular Subtype of High Grade Serous Ovarian Cancer Representing MAPK Pathway Activation and Platinum Resistance

【24h】

Identification of a Molecular Subtype of High Grade Serous Ovarian Cancer Representing MAPK Pathway Activation and Platinum Resistance

机译：代表MAPK途径激活和铂耐药的高级浆液性卵巢癌的分子亚型的鉴定。

获取原文

获取原文并翻译 | 示例

获取外文期刊封面封底 >>

开具论文收录证明 >>

文献代查 >>

页面导航

著录项
相似文献
相关主题

著录项

来源
《The Journal of molecular diagnostics: JMD》 |2016年第6期|共1页
作者
Brown C. A.; McCabe N.; Gourley C.; McCavigan A.; Michle C. O.; El-Helai A.; Price B.; McGivern N.; Churchman M.; OBrien E. J.; Hill L.; Davison T. S.; Williams A.; McCluggage W. G.; Keating K. E.; Harkin D. P.; Kennedy R.;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类临床医学;
关键词

相似文献

外文文献
中文文献
专利

1. Identification of a Molecular Subtype of High Grade Serous Ovarian Cancer Representing MAPK Pathway Activation and Platinum Resistance [J] . Brown C. A., McCabe N., Gourley C., The Journal of molecular diagnostics: JMD . 2016,第6期

机译：代表MAPK途径激活和铂耐药的高级浆液性卵巢癌的分子亚型的鉴定。
2. Beside P53 and PTEN: Identification of molecular alterations of the RAS/MAPK and PI3K/AKT signaling pathways in high-grade serous ovarian carcinomas to determine potential novel therapeutic targets [J] . Chen Shuhui, Cavazza Elisa, Barlier Catherine, Oncology letters . 2016,第5aPta1期

机译：除了P53和PTEN之外：鉴定高级浆液卵巢癌中RAS / MAPK和PI3K / AKT信号传导途径的分子改变，以确定潜在的新疗效目标
3. MAPK Activation Predicts Poor Outcome and the MEK Inhibitor, Selumetinib, Reverses Antiestrogen Resistance in ER-Positive High-Grade Serous Ovarian Cancer [J] . Hew Karina E., Miller Philip C., El-Ashry Dorraya, Clinical cancer research: an official journal of the American Association for Cancer Research . 2016,第4期

机译：MAPK激活预测不良结果，MEK抑制剂Selumetinib逆转ER阳性高级别浆液性卵巢癌的抗雌激素耐药性。
4. Molecular Markers of Serous Ovarian Cancer Aggressiveness and Surgical Outcome by Ambient Ionization Mass Spectrometry Imaging [C] . Marta Sans Escofet, Kshipra Gharpure, Jialing Zhang, ASMS Conference on Mass Spectrometry and Allied Topics . 2016

机译：环境电离质谱成像的浆液卵巢癌侵蚀性和手术结果的分子标记
5. Characterization of Precancerous Mutations in Ulcerative Colitis-Associated Colorectal Cancer and High-Grade Serous Ovarian Cancer via Duplex Sequencing [D] . Baker, Kathryn Terese 2018

机译：溃疡性结肠炎相关大肠癌和高级别浆液性卵巢癌癌前突变的双重测序表征。
6. Beside P53 and PTEN: Identification of molecular alterations of the RAS/MAPK and PI3K/AKT signaling pathways in high-grade serous ovarian carcinomas to determine potential novel therapeutic targets [O] . Shuhui Chen, Elisa Cavazza, Catherine Barlier, -1

机译：除了P53和PTEN：鉴定高级别浆液性卵巢癌中RAS / MAPK和PI3K / AKT信号通路的分子改变以确定潜在的新型治疗靶标
7. Beside P53 and PTEN: Identification of molecular alterations of the RAS/MAPK and PI3K/AKT signaling pathways in high-grade serous ovarian carcinomas to determine potential novel therapeutic targets [O] . Chen, Shuhui, Cavazza, Elisa, Barlier, Catherine, 2016

机译：除了P53和PTEN：鉴定高级别浆液性卵巢癌中RAS / MAPK和PI3K / AKT信号通路的分子改变，以确定潜在的新型治疗靶标

Identification of a Molecular Subtype of High Grade Serous Ovarian Cancer Representing MAPK Pathway Activation and Platinum Resistance

著录项

相似文献

相关主题

期刊订阅